March 16, 2026
We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.
Oxford PharmaGenesis recently attended the 8th annual World Orphan Drug Congress (WODC) in Barcelona, which highlighted the importance of early and effective collaboration and communication between patients and other healthcare stakeholders, particularly in the rare disease space.
We were busy at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress in Glasgow last month.
It’s hard to believe that it’s only 12 months since Oxford PharmaGenesis officially launched its Patient Engagement Practice at the 2016 eyeforpharma Patient Summit.
Oxford PharmaGenesis, Inc. has been certified a ‘Great Place to Work’ by a leading global authority on high-performing workplace cultures.
On Friday 8 September, representatives from patient organizations and pharmaceutical companies gathered at the Royal Society in London to attend the workshop ‘Working with industry’, which was run by Findacure.
Oxford PharmaGenesis is thrilled to announce the expansion of our global presence with the opening of a new office in Melbourne, Australia.
